Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Zollinger-Ellison Syndrome 1Thrombosis 1Thromboembolism 1Stomach Ulcer 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Lymphoma, Follicular 1Ischemic Stroke 1Esophagitis, Peptic 1

Interventions

Enoxaparin 4Saline Solution 3Warfarin 2Tinzaparin 2Dalteparin 2Aspirin 2enoxaparin sodium 1edoxaban 1alvocidib 1Watchful Waiting 1Tranexamic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Nadroparin 1Lenalidomide 1Ketoconazole 1Immunoenzyme Techniques 1High-Energy Shock Waves 1Heparin, Low-Molecular-Weight 1Heparin 1Gemcitabine 1Fondaparinux 1Fluorodeoxyglucose F18 1Fluoridation 1Estramustine 1Enzyme-Linked Immunosorbent Assay 1Doxorubicin 1Docetaxel 1Clopidogrel 1Bleeding Time 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thromboembolism × Clopidogrel × Clear all
NCT00020189 2013-06-19

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡